No less than ​ prior to the reasonably anticipated date for a First Commercial Sale of a Product in the Territory, [[Forty Seven:Organization]] shall prepare and present at the next-occurring JSC meeting for discussion a global sales and marketing strategy (e.g., reimbursement, positioning, segmentation, sales force, messaging and branding) for the Products worldwide (such strategy, and any amendments thereto, the “Global Commercialization Strategy”). Subject to Section 3.3.2, each Party’s Commercialization Plan of the Products in each Territory shall be, to the extent reasonably practicable, aligned with the Global Commercialization Strategy.

Global Commercialization Strategy. ​ PARTNER shall develop and provide to REGENX through the JCC a global commercialization strategy for such Licensed Product in a particular Indication throughout the Territory (each, a “Global Commercialization Strategy”), which Global Commercialization Strategy shall include ​.

Global Commercialization Strategy. Fate acknowledges that Janssen’s global commercialization strategy for the Profit Share Product will inform the U.S. Commercialization Plan. Janssen will develop, with input from Fate through its participation on the USJCC, the global commercialization strategy, which will set forth overall brand strategy/stewardship elements for the Profit Share Product, including brand name, trademarks, global positioning, global messaging, competitive readiness, life cycle management, and guidance for medical affairs and other functions. Janssen will provide the JSC with a copy of the global commercialization strategy and any updates on a quarterly basis, for review and discussion (but not approval) by the JSC.

Global Branding Strategy. Acorda shall have the right, from time to time during the Term, to implement (and thereafter modify and update) a global branding strategy, including global messaging, for the Licensed Product for use in the Field throughout the world (the “Global Branding Strategy”). To the extent Acorda determines to utilize such Global Branding Strategy, Licensee shall use Commercially Reasonable Efforts to adhere to the Global Branding Strategy in its Commercialization of the Licensed Product in the Territory, including with respect to any Promotional Materials.

review each Commercialization Plan and Commercialization Strategy in the Territory, including all updates and amendments thereto, including for the purpose of alignment with Aguettant’s global commercialization strategy for Products, including any modification of branding of the Products in the Territory;

Global Branding Strategy. [[Agenus:Organization]] will control the global branding strategy (including global positioning, messages, logo, colors and other visual branding elements) for the Licensed Antibodies and Licensed Products throughout the world (the “Global Branding Strategy”). Betta will comply with the Global Branding Strategy; provided, however, that Betta will be permitted to deviate from the Global Branding Strategy for a Licensed Product in relation to the Territory to the extent ​ (such deviations “Permissible Deviations”). Betta will discuss any Permissible Deviation from the Global Branding Strategy with [[Agenus:Organization]] and consider any comments [[Agenus:Organization]] may have with respect thereto ​.

“Global Commercialization Strategy” has the meaning set forth in [Section 6.1.1].

review the Commercialization Plan prepared by Licensee for alignment with the global commercialization strategy for Products, and provide comments thereto;

Global Branding Strategy. The JCC will develop a global branding strategy for the Products in the Field in the Territory, including, with respect to each Product, a life cycle plan, brand vision, positioning, key messaging, concept and imagery, Trademarks (including name and logos), brand public relations and supporting market research (the “Global Branding Strategy”) and submit such strategy to the JSC for approval.

Global Commercialization Costs. As between the Parties, PARTNER shall be responsible for all costs and expenses in connection with the Commercialization of Licensed Products in the Licensed Field throughout all countries in the Territory other than the [[Address A:Address]].